New Era Capital Partners

2018

Founded

20

Investments

Israel

Offices

Venture Fund

Investor Type

About

New Era Capital Partners is a venture capital firm established in 2018, headquartered in Tel Aviv, Israel, with an additional office in Boston, USA. The firm specializes in early-stage investments, focusing on companies at the Seed to Series B stages. They typically invest between $1 million and $10 million, ensuring their portfolio companies have sufficient runway to grow and thrive.

New Era Capital Partners emphasizes partnerships with entrepreneurs who possess deep domain expertise and a commitment to disrupting large markets and ecosystems. The firm values integrity, humility, passion, and the integration of Environmental, Social, and Governance (ESG) and Diversity, Equity, and Inclusion (DEI) principles within organizations. Their global presence spans North America, Europe, and Asia, leveraging extensive experience and connections to support companies with Israeli roots expanding globally.

The team comprises former senior executives who provide proactive guidance across business strategy, finance, and technology, assisting entrepreneurs in their growth journeys.

Investment Focus

HQ Locations

Portfolio Companies

Optibus, User1st, Twine, Espresa, Variantyx, Otoma, Delegate, Vi, Hyliion, Delegate

Gepgraphic Focus

North America, Europe, Asia

Key Differentiators

Early-stage investments from Seed to Series B, Investments ranging from $1 million to $10 million, Emphasis on ESG and DEI values, Global presence with offices in Tel Aviv and Boston, Proactive support from former senior executives

Thypical Investment Size

$1 million to $10 million

Total Funds Raised

$150 million

Visit Website

BioTech

Tel Aviv

Seed

Series A

Series B

Series C

Series D

Israel